These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36746784)

  • 1. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Diabetes Metab J; 2023 Mar; 47(2):211-219. PubMed ID: 36746784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
    Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
    Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria.
    Russel-Szymczyk M; Valov V; Savova A; Manova M
    BMC Endocr Disord; 2019 Dec; 19(1):132. PubMed ID: 31796048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM.
    Jacober SJ; Rosenstock J; Bergenstal RM; Prince MJ; Qu Y; Beals JM
    Diabetes Obes Metab; 2014 Apr; 16(4):351-6. PubMed ID: 24719911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A; Nafees B; Barnett AH; Heller S; Ploug UJ; Lammert M; Bøgelund M
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN.
    Mitchell BD; He X; Sturdy IM; Cagle AP; Settles JA
    Endocr Pract; 2016 Feb; 22(2):123-35. PubMed ID: 26484405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.
    Kostev K; Gläser S; Jacob L
    J Diabetes Sci Technol; 2017 Sep; 11(5):996-1000. PubMed ID: 28420259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
    Guillermin AL; Samyshkin Y; Wright D; Nguyen T; Villeneuve J
    J Med Econ; 2011; 14(2):207-16. PubMed ID: 21361858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus.
    Puspitasari AD; Kusuma H; Ratri DMN; Wibisono C; Suprapti B
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31926091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus.
    Woo VC
    Clin Ther; 2017 Aug; 39(8S2):S12-S33. PubMed ID: 28187863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
    Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
    Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
    van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
    Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V).
    Liu J; Jiang X; Xu B; Wang G; Cui N; Zhang X; Liu J; Mu Y; Guo L
    Adv Ther; 2020 Apr; 37(4):1675-1687. PubMed ID: 32130661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study.
    Hussein Z; Kamaruddin NA; Chan SP; Jain A; Uppal S; Bebakar WMW;
    Diabetes Res Clin Pract; 2017 Nov; 133():40-49. PubMed ID: 28888148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-series analysis of recent antihyperglycemic medication prescribing trends for a diverse sample of Medicare enrollees with type 2 diabetes mellitus in an integrated health system.
    Miller MJ; DiNucci AJ; Jalalzai R; Rabinovich N; Roblin DW
    Am J Health Syst Pharm; 2022 Jun; 79(12):950-959. PubMed ID: 35176753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EADSG Guidelines: Insulin Therapy in Diabetes.
    Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
    Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan.
    Urakami T; Suzuki J; Mugishima H; Amemiya S; Sugihara S; Kawamura T; Kikuchi T; Sasaki N; Matsuura N; Kitagawa T
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():51-61. PubMed ID: 23330246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patients.
    Siegmund T; Pfohl M; Forst T; Pscherer S; Bramlage P; Foersch J; Borck A; Seufert J
    Diabetes Metab Syndr; 2017; 11(1):51-57. PubMed ID: 27578616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.